Rescue of Helicobacter pylori–Induced Cytotoxicity by Red Ginseng (original) (raw)

References

  1. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, Hoiby N: Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother 41:961–964, 1997
    PubMed Google Scholar
  2. Liu CX, Xiao PG: Recent advances on ginseng research in China. J Ethnopharmacol 36:27–38, 1992
    Article PubMed Google Scholar
  3. Smolinski AT, Pestka JJ: Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem Toxicol 41:1381–1390, 2003
    Article PubMed Google Scholar
  4. O’Hara M, Kiefer D, Farrell K, Kemper K: A review of 12 commonly used medicinal herbs. Arch Fam Med 7:523–536, 1998
    PubMed Google Scholar
  5. Di Carlo G, Mascolo N, Izzo AA, Capasso F: Flavonoids; old and new aspects of a class of natural therapeutic drugs. Life Sci 65:337–353, 1999
    PubMed Google Scholar
  6. Shao ZH, Xie JT, Vanden Hoek TL, Mehendale S, Aung H, Li CQ, Qin Y, Schumacker PT, Becker LB, Yuan CS: Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 1670:165–171, 2004
    PubMed Google Scholar
  7. Bae EA, Han MJ, Baek NI, Kim DH: In vitro anti-Helicobacter pylori activity of panaxytriol isolate from ginseng. Arch Pharm Res 24:297–299, 2001
    PubMed Google Scholar
  8. Park EK, Choo MK, Han MJ, Kim DH: Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 133:113–120, 2004
    PubMed Google Scholar
  9. Yu SC, Li XY: Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol Sin 21:915–918, 2000
    PubMed Google Scholar
  10. Li SH, Chu Y: Anti-inflammatory effects of total saponins of Panax notoginseng. Zhongguo Yao Li Xue Bao 20:551–554, 1999
    PubMed Google Scholar
  11. Belogortseva NI, Yoon JY, Kim KH: Inhibition of Helicobacter pylori hemagglutination by polysaccharide fractions from roots of Panax ginseng. Planta Med 66:217–220, 2000
    PubMed Google Scholar
  12. Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, Ikejima T: Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 23(4):315–322, 2002
    PubMed Google Scholar
  13. Park JA, Lee KY, Oh YJ, Kim KW, Lee SK: Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 121:73–81, 1997
    PubMed Google Scholar
  14. Liu WK, Xu SX, Che CT: Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 67:1297–1306, 2000
    PubMed Google Scholar
  15. Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH: Protective effect of ginsenoside Rg1 on MPP+ induced apoptosis in SHSY5Y cells. J Neural Transm 110:835–845, 2003
    PubMed Google Scholar
  16. Lee EH, Cho SY, Kim SJ, Shin ES, Chang HK, Kim DH, Yeom MH, Woe KS, Lee J, Sim YC, Lee TR: Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J Invest Dermatol 121:607–613, 2003
    PubMed Google Scholar
  17. International Agency for Research on Cancer: Schistosomes, liver flukes and Helicobacter pylori. Monograph 61. Lyon, France, IARC, 1994
  18. Everett S, White K, Drake I, Schorah C, Calvert R, Skinner C, Stinger M, Miller D, Dixon M, Chalmers D, Axon A: The effect of Helicobacter pylori infection on levels of DNA damage in gastric epithelial cells. Helicobacter pylori 7:271–280, 2002
    Google Scholar
  19. Kikuchi S: Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 5:6–15, 2002
    PubMed Google Scholar
  20. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789, 2001
    PubMed Google Scholar
  21. Israel DA, Peek RM: Pathogenesis of _Helicobacter pylori_-induced gastric inflammation. Aliment Pharmacol Ther 15:1271–1290, 2001
    PubMed Google Scholar
  22. Hahm KB, Lee KJ, Kim JH, Cho SW, Chung MH: Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. Dig Dis Sci 43:72S–77S, 1998
    PubMed Google Scholar
  23. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD: Activation of IL–8 gene expression by _Helicobacter pylori_is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160: 2401–2407, 1998
    PubMed Google Scholar
  24. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Mechanisms involved in _Helicobacter pylori_-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 65:3218–3124, 1997
    PubMed Google Scholar
  25. Naito Y, Yoshikawa T: Molecular and cellular mechanisms involved in _Helicobacter pylori_-induced inflammation and oxidative stress. Free Radic Biol Med 33:323–336, 2002
    PubMed Google Scholar
  26. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601, 1988
    PubMed Google Scholar
  27. Singh NP, McCoy RR, Tice EL, Schneider A: Simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191, 1988
    PubMed Google Scholar
  28. Collins AR: The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol. 26: 249–261, 2004
    PubMed Google Scholar
  29. Everett SM, White KL, Drake IM, Schorah CJ, Calvert RJ, Skinner C, Stringer MD, Miller D, Dixon MF, Chalmers DM, Axon AT: The effect of Helicobacter pylori infection on levels of DNA damage in gastric epithelial cells. Helicobacter 7:271–280, 2002
    PubMed Google Scholar
  30. Van der Woude H, Gliszczynska–Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM: Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 200:41–47, 2003
    PubMed Google Scholar
  31. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM: Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 151:1695–1703, 1997
    PubMed Google Scholar
  32. Jones NL, Day AS, Jennings HA, Sherman PM: Helicobacter pylori induce gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 67:4237–4242, 1999
    PubMed Google Scholar
  33. Chiou CC, Chan CC, Sheu DL, Chen KT, Li YS, Chan EC: Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 48:598–604, 2001
    PubMed Google Scholar
  34. Keates S, Keates AC, Warny M, Peek RM Jr, Murray PG, Kelly CP: Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cagminus; Helicobacter pylori. J Immunol 163:5552–5559, 1999
    PubMed Google Scholar
  35. Munzenmaier A, Lange C, Glocker E, Covacci A, Moran A, Bereswill S, Baeuerle PA, Kist M, Pahl HL: A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 159:6140–6147, 1997
    PubMed Google Scholar
  36. Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T, Shiratori Y, Omata M: Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signaling pathway in gastric cancer cell. Gut 49:18–22, 2001
    PubMed Google Scholar
  37. Crowe SE, Alvarez L, Cytoc M, Hunt DH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB: Expression of interleukin 8 and CD 54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65–74, 1995
    PubMed Google Scholar
  38. Nozawa Y, Nishihara K, Peek RM, Nakano M, Uji T, Ajioka H, Matsuura N, Miyake H: Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem Pharmacol 64:21–30, 2002
    PubMed Google Scholar
  39. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y, Omata M: Distinct mechanism of _Helicobacter pylori_-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 276:44856–44864, 2001
    PubMed Google Scholar
  40. Mahady GB, Pendland SL, Yun G, Lu ZZ: Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 22:4179–4181, 2002
    PubMed Google Scholar
  41. Yanaka A, Zhang S, Tauchi M, Suzuki H, Shibahara T, Matsui H, Nakahara A, Tanaka N: Daily intake of sulforaphane-rich broccoli sprouts prevents progression of high salt diet-induced gastric atrophy in _H. pylori_-infected C57/BL6 mice in vivo. Gastroenterology124:A-5, 2003
    Google Scholar
  42. Sivam GP: Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr 131:1106S–1108S, 2001
    PubMed Google Scholar
  43. Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, Wakabayashi K: Suppressive effects of garlic extract on _Helicobacter pylori_-induced gastritis in Mongolian gerbils. Cancer Lett 187:61–68, 2002
    PubMed Google Scholar

Download references